Situation: A 64-year-old man with chronic atrial fibrillation and hypertension takes digoxin 0.125 mg and hydrochlorothiazide 25 mg orally every morning. He has no heart failure or kidney disease. He is admitted with generalized weakness, leg cramps, and palpitations. His serum potassium is 2.9 mEq/L (3.5–5.0 mEq/L). The hydrochlorothiazide is held, and he has a peripheral intravenous (IV) catheter in his forearm. His cardiac monitor shows flattened T waves and prominent U waves. Which explanation of how hydrochlorothiazide lowered his potassium is correct?

Thiazides block sodium–chloride reabsorption in the distal convoluted tubule, so more sodium reaches the collecting duct. There it is reabsorbed in exchange for potassium (and hydrogen ions), which are lost in the urine. The flattened T waves and U waves reflect the resulting hypokalemia.

Mechanism of thiazide-induced hypokalemia

Thiazide diuretics such as hydrochlorothiazide act primarily on the distal convoluted tubule (DCT), where they inhibit the Na⁺–Cl⁻ cotransporter (NCC). This reduces sodium and chloride reabsorption at that site. As a result, a larger amount of sodium remains in the tubular fluid and travels downstream to the collecting duct.

In the collecting duct, sodium is reabsorbed through epithelial sodium channels (ENaC) in principal cells. This sodium entry creates a negative electrical gradient in the tubular lumen, which drives the secretion of potassium through renal outer medullary potassium (ROMK) channels and, under high-flow conditions, large-conductance potassium (BK) channels ^[1]. The more sodium delivered to the collecting duct, the greater the potassium secretion and urinary potassium loss. This explains why thiazide use produces hypokalemia.

The option that best captures this sequence is: more sodium reaches the collecting duct, where it is exchanged for potassium. The exchange is not a direct one-for-one molecular swap; rather, sodium reabsorption generates the electrochemical driving force for potassium secretion. The net clinical effect is potassium wasting.

Watch out! Thiazides do not act on the thick ascending limb of the loop of Henle. That is the site of loop diuretics such as furosemide, which inhibit the Na⁺–K⁺–2Cl⁻ cotransporter (NKCC2). Thiazides also do not shift potassium into cells like insulin or beta-agonists do, and they do not block aldosterone. In fact, the volume contraction and sodium loss caused by thiazides can activate the renin–angiotensin–aldosterone system, which would tend to increase potassium excretion further.

The ECG findings in this patient are consistent with hypokalemia. Flattened or inverted T waves and prominent U waves reflect delayed ventricular repolarization. In severe cases, the T and U waves may fuse, producing a pseudo-prolonged QT interval, as described in a case of thiazide-induced hypokalemic paralysis ^[2]. The potassium value of 2.9 mEq/L is below the reference range of 3.5–5.0 mEq/L and places the patient at risk for both muscle weakness and cardiac dysrhythmias.

Distractor	Why it is incorrect
Blocks potassium reabsorption in the thick ascending limb	That describes loop diuretics, not thiazides. Thiazides act on the distal convoluted tubule.
Shifts potassium into cells, as insulin does	Thiazides do not have a direct cellular shift effect. Insulin, beta-agonists, and alkalosis cause intracellular potassium shifts.
Blocks aldosterone, so the collecting duct excretes more potassium	Aldosterone antagonists reduce potassium excretion. Thiazides do not block aldosterone; they may indirectly increase aldosterone activity.
More sodium reaches the collecting duct, where it is exchanged for potassium	Correct. Increased distal sodium delivery enhances potassium secretion in the collecting duct.

Key point! For a patient taking digoxin, hypokalemia is especially dangerous because low extracellular potassium increases digoxin binding to the Na⁺/K⁺-ATPase pump, potentiating digoxin toxicity. This patient’s palpitations and ECG changes should prompt immediate potassium repletion and close cardiac monitoring.

The role of ROMK endocytosis in potassium conservation is relevant to understanding why the kidney normally prevents excessive potassium loss during dietary deficiency ^[1]. However, when thiazides increase distal sodium delivery, the electrochemical gradient favoring potassium secretion overrides these conservation mechanisms, leading to urinary potassium wasting.